![Transparency Market Researchが調査・発行した産業分析レポートです。組み換え因子Cアッセイ（rFC）の世界市場2019-2027：ブランド別（PyroGene [PyroGene Bulk rFC {2,880テスト}、PyroGene rFC {192テスト}］、EndoNext[EndoZyme II、EndoZyme II GO、EndoLisa]）、エンドユーザー別 / Recombinant Factor C Assay Market (Brand: PyroGene [PyroGene Bulk rFC {2,880 Tests} and PyroGene rFC {192 Tests}] and EndoNext [EndoZyme II, EndoZyme II GO, and EndoLisa]; and End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Contract Research Organizations [CROs]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TMR2006032資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/report-contents-93.gif) | • レポートコード：TMR2006032 • 出版社/出版日：Transparency Market Research / 2020年3月 • レポート形態：英文、PDF、172ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、組み換え因子Cアッセイ（rFC）の世界市場について、序論、仮定、調査手法、エグゼクティブサマリー、市場動向、キーインサイト、ブランド別（PyroGene [PyroGene Bulk rFC {2,880テスト}、PyroGene rFC {192テスト}］、EndoNext[EndoZyme II、EndoZyme II GO、EndoLisa]）分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ）分析、競争状況などを総合的に調査・分析して掲載しております。 ・序論 ・仮定 ・調査手法 ・エグゼクティブサマリー ・市場動向 ・キーインサイト ・組み換え因子Cアッセイ（rFC）の世界市場規模：ブランド別（PyroGene [PyroGene Bulk rFC {2,880テスト}、PyroGene rFC {192テスト}］、EndoNext[EndoZyme II、EndoZyme II GO、EndoLisa]） ・組み換え因子Cアッセイ（rFC）の世界市場規模：エンドユーザー別 ・組み換え因子Cアッセイ（rFC）の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ） ・競争状況 |
Recombinant Factor C Assay Market – Scope of the Report
TMR’s report on the global recombinant factor C assay market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period i.e. from 2019 to 2027. The report provides the overall revenue of the global recombinant factor C assay market for the 2017–2027 period, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compounded annual growth rate (CAGR) for the global recombinant factor C assay market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global recombinant factor C assay market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global recombinant factor C assay market.
The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competition dynamics in the global recombinant factor C assay market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global recombinant factor C assay market. The next section of the report highlights the USPs, which include value chain analysis, key industry developments, patent analysis, regulatory scenario, and institutes involved in research studies using horseshoe crabs in the global recombinant factor C assay market.
The report delves into the competition landscape of the global recombinant factor C assay market. Key players operating in the global recombinant factor C assay market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global recombinant factor C assay market report.
Key Questions Answered in Global Recombinant Factor C Assay Market Report
How much sales revenue would be generated by recombinant factor C assay across all regions during the forecast period?
What are key trends in the global recombinant factor C assay market?
What are major drivers, restraints, and opportunities in the global recombinant factor C assay market?
Which regional market is set to expand at the most rapid CAGR during the forecast period?
Which end user segment would generate the maximum revenue by 2027 and which brand segment would expand at the most rapid CAGR during the forecast period?
Recombinant Factor C Assay Market – Research Objectives and Research Approach
The comprehensive report on the global recombinant factor C assay market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and health care compliances laid down by accredited agencies in the purview of research in the global recombinant factor C assay market. It is followed by market introduction, market dynamics, and an overview of the global recombinant factor C assay market, which includes TMR’s analysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global recombinant factor C assay market report highlights the USPs, which include regulatory scenarios for recombinant factor C assay globally, market value chain analysis, and developments in the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
Revenue generated by key players in the global recombinant factor C assay market has been mapped to ascertain the size of the global recombinant factor C assay market, in terms of value. The forecast presented here assesses the total revenue generated in the global recombinant factor C assay market. In order to provide an accurate forecast, we initiated by sizing up the current recombinant factor C assay market with the help of the parent market.
The report analyzes the global recombinant factor C assay market in terms of brand, end user, and region. Key segments under each criteria have been studied at length and the market share for each of these by the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global recombinant factor C assay market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Acronyms
3. Research Methodology
4. Executive Summary: Global Recombinant Factor C Assay Market
5. Market Overview
5.1. Definition
5.2. Market Indicators
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunities
5.4. Global Recombinant Factor C Assay Market Revenue (US$ Mn) Forecast 2017–2027
5.5. Global Recombinant Factor C Assay Market Outlook
6. Key Insights
6.1. Value Chain Analysis
6.2. Key Industry Events
6.3. Patent Analysis
6.4. Product Features & USPs
6.5. Overview of Pyrogen Testing Products Market
6.5.1. Pyrogen Testing- Service Providers
6.5.2. Pyrogen Testing Products Marketing, by Country/Region
6.6. Overview of Limulus Amoebocyte Lysate (LAL) Tests
6.6.1. Number of Assays Performed
6.6.2. Cost per Assay and Turn Around Time
6.7. Regulatory Scenario, by Country/Region
6.8. Institutes Involved in Research Studies using Horseshoe Crabs
7. Global Recombinant Factor C Assay Market Analysis and Forecast, by Brand
7.1. Introduction
7.2. Global Recombinant Factor C Assay Market Value Share Analysis, by Brand
7.3. Global Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027
7.3.1. PyroGene
7.3.1.1. PyroGene Bulk rFC (2,880 tests)
7.3.1.2. PyroGene rFC (192 tests)
7.3.2. EndoNext
7.3.2.1. Endozyme II
7.3.2.2. Endozyme II GO
7.3.2.3. EndoLisa
7.4. Global Recombinant Factor C Assay Market Attractiveness, by Brand
8. Global Recombinant Factor C Assay Market Analysis and Forecast, by End-user
8.1. Introduction
8.2. Global Recombinant Factor C Assay Market Value Share Analysis, by End-user
8.3. Global Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027
8.3.1. Pharmaceutical Companies
8.3.2. Biotechnology Companies
8.3.3. Medical Device Companies
8.3.4. Contract Research Organizations (CROs)
8.4. Global Recombinant Factor C Assay Market Attractiveness, by End-user
9. Global Recombinant Factor C Assay Market Analysis and Forecast, by Region
9.1. Regional Outlook
9.2. Introduction
9.3. Global Recombinant Factor C Assay Market Value Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Recombinant Factor C Assay Market Attractiveness, by Region
10. North America Recombinant Factor C Assay Market Analysis and Forecast
10.1. Key Findings
10.2. North America Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027
10.2.1. PyroGene
10.2.1.1. PyroGene Bulk rFC (2,880 tests)
10.2.1.2. PyroGene rFC (192 tests)
10.2.2. EndoNext
10.2.2.1. Endozyme II
10.2.2.2. Endozyme II GO
10.2.2.3. EndoLisa
10.3. North America Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027
10.3.1. Pharmaceutical Companies
10.3.2. Biotechnology Companies
10.3.3. Medical Device Companies
10.3.4. Contract Research Organizations (CROs)
10.4. North America Recombinant Factor C Assay Market Value Forecast, by Country, 2017–2027
10.4.1. U.S.
10.4.2. Canada
10.5. North America Recombinant Factor C Assay Market Attractiveness Analysis
10.5.1. By Brand
10.5.2. By End-user
10.5.3. By Country
11. Europe Recombinant Factor C Assay Market Analysis and Forecast
11.1. Key Findings
11.2. Europe Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027
11.2.1. PyroGene
11.2.1.1. PyroGene Bulk rFC (2,880 tests)
11.2.1.2. PyroGene rFC (192 tests)
11.2.2. EndoNext
11.2.2.1. Endozyme II
11.2.2.2. Endozyme II GO
11.2.2.3. EndoLisa
11.3. Europe Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027
11.3.1. Pharmaceutical Companies
11.3.2. Biotechnology Companies
11.3.3. Medical Device Companies
11.3.4. Contract Research Organizations (CROs)
11.4. Europe Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027
11.4.1. U.K.
11.4.2. Germany
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Rest of Europe
11.5. Europe Recombinant Factor C Assay Market Attractiveness Analysis
11.5.1. By Brand
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Asia Pacific Recombinant Factor C Assay Market Analysis and Forecast
12.1. Key Findings
12.2. Asia Pacific Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027
12.2.1. PyroGene
12.2.1.1. PyroGene Bulk rFC (2,880 tests)
12.2.1.2. PyroGene rFC (192 tests)
12.2.2. EndoNext
12.2.2.1. Endozyme II
12.2.2.2. Endozyme II GO
12.2.2.3. EndoLisa
12.3. Asia Pacific Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027
12.3.1. Pharmaceutical Companies
12.3.2. Biotechnology Companies
12.3.3. Medical Device Companies
12.3.4. Contract Research Organizations (CROs)
12.4. Asia Pacific Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027
12.4.1. China
12.4.2. India
12.4.3. Japan
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Recombinant Factor C Assay Market Attractiveness Analysis
12.5.1. By Brand
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Latin America Recombinant Factor C Assay Market Analysis and Forecast
13.1. Key Findings
13.2. Latin America Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027
13.2.1. PyroGene
13.2.1.1. PyroGene Bulk rFC (2,880 tests)
13.2.1.2. PyroGene rFC (192 tests)
13.2.2. EndoNext
13.2.2.1. Endozyme II
13.2.2.2. Endozyme II GO
13.2.2.3. EndoLisa
13.3. Latin America Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027
13.3.1. Pharmaceutical Companies
13.3.2. Biotechnology Companies
13.3.3. Medical Device Companies
13.3.4. Contract Research Organizations (CROs)
13.4. Latin America Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of Latin America
13.5. Latin America Recombinant Factor C Assay Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Middle East & Africa Recombinant Factor C Assay Market Analysis and Forecast
14.1. Key Findings
14.2. Middle East & Africa Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027
14.2.1. PyroGene
14.2.1.1. PyroGene Bulk rFC (2,880 tests)
14.2.1.2. PyroGene rFC (192 tests)
14.2.2. EndoNext
14.2.2.1. Endozyme II
14.2.2.2. Endozyme II GO
14.2.2.3. EndoLisa
14.3. Middle East & Africa Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027
14.3.1. Pharmaceutical Companies
14.3.2. Biotechnology Companies
14.3.3. Medical Device Companies
14.3.4. Contract Research Organizations (CROs)
14.4. Middle East & Africa Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of Middle East & Africa
14.5. Middle East & Africa Recombinant Factor C Assay Market Attractiveness Analysis
14.5.1. By Product
14.5.2. By End-user
14.5.3. By Country/Sub-region
15. Competition Landscape
15.1. Company Share Analysis
15.2. Company Profiles
15.2.1. Lonza Group
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. Hyglos GmbH – a bioMérieux Company
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
List of TablesTable 01: Patent Information – Pyrogene (Lonza)
Table 02: Patent Information – EndoLisa
Table 03: Patent Information – EndoZyme II GO
Table 04: Patent Information – Recombinant Factor C Assay Market
Table 05: Product Features & USPs – Recombinant Factor C Assays
Table 06: Pyrogen Testing- Service Providers
Table 07: Pyrogen Testing- Service Providers
Table 08: Pyrogen Testing Products Marketing
Table 09: Cost per Assay and Turn Around Time (LAL)
Table 10: Institutes Involved in Research Studies using Horseshoe Crabs
Table 11: Institutes Focused on Conversing Horseshoe Crabs
Table 12: Pyrogen Testing Market Offerings, By Company
Table 13: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027
Table 14: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027
Table 15: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027
Table 16: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027
Table 17: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Region, 2017–2027
Table 18: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country, 2017–2027
Table 19: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027
Table 20: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027
Table 21: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027
Table 22: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027
Table 23: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027
Table 24: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027
Table 25: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027
Table 26: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027
Table 27: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027
Table 28: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027
Table 29: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027
Table 30: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027
Table 31: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027
Table 32: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027
Table 33: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027
Table 34: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027
Table 35: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027
Table 36: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027
Table 37: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027
Table 38: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027
Table 39: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027
Table 40: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027
Table 41: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027
Table 42: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027